Total Payments
$13,633
2024 Payments
$18.38
Companies
64
Transactions
1,002
Medicare Patients
3,360
Medicare Billing
$227,805
Payment Breakdown by Category
Food & Beverage$13,581 (99.6%)
Education$52.48 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,581 | 995 | 99.6% |
| Education | $52.48 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,647 | 137 | $0 (2023) |
| Amgen Inc. | $1,518 | 88 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,428 | 117 | $0 (2023) |
| Lilly USA, LLC | $1,022 | 90 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $945.62 | 52 | $0 (2023) |
| PFIZER INC. | $842.23 | 78 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $472.77 | 31 | $0 (2023) |
| Merck Sharp & Dohme LLC | $437.74 | 37 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $426.57 | 35 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $359.34 | 30 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.38 | 1 | Astellas Pharma US Inc ($18.38) |
| 2023 | $1,763 | 123 | ABBVIE INC. ($493.35) |
| 2022 | $2,360 | 174 | ABBVIE INC. ($414.59) |
| 2021 | $2,159 | 173 | AbbVie Inc. ($428.31) |
| 2020 | $1,795 | 119 | AstraZeneca Pharmaceuticals LP ($258.05) |
| 2019 | $1,450 | 114 | Amgen Inc. ($225.03) |
| 2018 | $1,513 | 107 | Amgen Inc. ($314.05) |
| 2017 | $2,574 | 191 | GlaxoSmithKline, LLC. ($253.96) |
All Payment Transactions
1,002 individual payment records from CMS Open Payments — Page 2 of 41
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Bone Health | ||||||
| 09/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: Diabetes | ||||||
| 09/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: RESPIRATORY | ||||||
| 08/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | ABBVIE INC. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $2.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Diabetes | ||||||
| 08/15/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: RESPIRATORY | ||||||
| 08/09/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Bone Health | ||||||
| 08/08/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Neuroscience | ||||||
| 08/07/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: NEUROSCIENCE | ||||||
| 08/02/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/27/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Inflammation | ||||||
| 07/26/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.61 | General |
| 07/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Neuroscience | ||||||
| 07/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Biological | ||||||
| 07/12/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 815 | 1,480 | $155,969 | $42,469 |
| 2022 | 16 | 767 | 1,411 | $149,901 | $43,720 |
| 2021 | 16 | 805 | 1,473 | $182,152 | $56,954 |
| 2020 | 15 | 973 | 1,781 | $179,269 | $84,663 |
Total Patients
3,360
Total Services
6,145
Medicare Billing
$227,805
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 302 | 641 | $95,509 | $24,460 | 25.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 180 | 180 | $33,480 | $7,531 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 56 | $5,656 | $2,079 | 36.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 27 | 27 | $2,106 | $1,971 | 93.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,835 | $1,722 | 44.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 21 | 21 | $5,796 | $1,445 | 24.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 28 | 28 | $1,120 | $779.24 | 69.6% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 46 | 46 | $1,334 | $696.13 | 52.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 44 | 62 | $2,480 | $583.89 | 23.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 55 | $2,200 | $453.67 | 20.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 12 | $1,044 | $410.96 | 39.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 11 | 12 | $588.00 | $235.60 | 40.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 31 | 37 | $240.50 | $79.20 | 32.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 24 | 290 | $580.00 | $21.68 | 3.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 389 | 793 | $118,157 | $31,180 | 26.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 51 | 52 | $4,032 | $3,571 | 88.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 46 | $4,646 | $1,673 | 36.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $1,728 | $1,580 | 91.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 38 | 38 | $7,068 | $1,482 | 21.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 43 | $1,720 | $1,132 | 65.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 33 | 69 | $2,760 | $575.85 | 20.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 14 | $1,218 | $536.80 | 44.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 18 | 18 | $720.00 | $476.82 | 66.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 36 | 49 | $1,960 | $453.07 | 23.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 12 | $3,816 | $441.50 | 11.6% |
About Dr. J . Timothy Hodges, MD
Dr. J . Timothy Hodges, MD is a Family Medicine healthcare provider based in Little Rock, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902802465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. J . Timothy Hodges, MD has received a total of $13,633 in payments from pharmaceutical and medical device companies, with $18.38 received in 2024. These payments were reported across 1,002 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($13,581).
As a Medicare-enrolled provider, Hodges has provided services to 3,360 Medicare beneficiaries, totaling 6,145 services with total Medicare billing of $227,805. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Little Rock, AR
- Active Since 06/21/2005
- Last Updated 11/21/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902802465
Products in Payments
- TRELEGY ELLIPTA (Drug) $761.61
- VRAYLAR (Drug) $719.30
- Aimovig (Biological) $669.29
- FARXIGA (Drug) $658.56
- EMGALITY (Drug) $523.19
- NURTEC ODT (Drug) $459.36
- UBRELVY (Drug) $404.55
- JARDIANCE (Drug) $353.70
- Prolia (Biological) $277.49
- Livalo (Drug) $252.18
- Trintellix (Drug) $228.28
- QULIPTA (Drug) $222.99
- Synthroid (Drug) $211.77
- TRULICITY (Drug) $208.25
- EVENITY (Biological) $194.05
- JANUVIA (Drug) $192.38
- LYRICA (Drug) $185.52
- SHINGRIX (Biological) $176.03
- BREO (Drug) $164.86
- SYNTHROID (Drug) $152.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Little Rock
Dr. Kevin Roberts, Md, MD
Family Medicine — Payments: $133,330
Family Medicine $133,330
Dr. Derek Lewis, M.d, M.D
Family Medicine — Payments: $117,470
Family Medicine $117,470
Dr. Harold Betton, M.d, M.D
Family Medicine — Payments: $23,468
Family Medicine $23,468
Dr. Oksana Melnyk, M.d, M.D
Family Medicine — Payments: $14,185
Family Medicine $14,185
Benjamin Mcdonald, D.o, D.O
Family Medicine — Payments: $13,868
Family Medicine $13,868
Dr. Thomas Moore, Md, MD
Family Medicine — Payments: $13,080
Family Medicine $13,080